|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:Dasatinib
gptkb:dasatinib
|
|
gptkbp:approves
|
gptkb:legislation
gptkb:Australia
gptkb:Japan
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:class
|
Tyrosine Kinase Inhibitor
|
|
gptkbp:clinical_trial
|
NC T00366124
NC T00481247
NC T00508562
NC T00728950
NC T01207440
|
|
gptkbp:contraindication
|
Pregnancy
Severe Liver Impairment
Hypersensitivity to Dasatinib
|
|
gptkbp:dosage_form
|
gptkb:tablet
|
|
gptkbp:effective_date
|
2006-06-28
|
|
gptkbp:has_ability
|
100 mg
50 mg
20 mg
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sprycel
|
|
gptkbp:ingredients
|
gptkb:Dasatinib
C22 H26 Cl N5 O2 S
|
|
gptkbp:interacts_with
|
gptkb:Warfarin
Antacids
CY P3 A4 Inducers
CY P3 A4 Inhibitors
|
|
gptkbp:is_atype_of
|
L01 X E05
|
|
gptkbp:is_monitored_by
|
Electrolytes
Complete Blood Count
Liver Function Tests
|
|
gptkbp:is_used_for
|
gptkb:healthcare_organization
gptkb:Chronic_Myeloid_Leukemia
|
|
gptkbp:manager
|
Oral
|
|
gptkbp:manufacturer
|
gptkb:Bristol-Myers_Squibb
|
|
gptkbp:marketed_as
|
gptkb:legislation
gptkb:Australia
gptkb:Japan
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:packaging
|
gptkb:beer
Blister Pack
|
|
gptkbp:side_effect
|
gptkb:Nausea
Diarrhea
Fatigue
Headache
Rash
|
|
gptkbp:storage
|
Room Temperature
Protect from moisture
|
|
gptkbp:type_of
|
302962-49-8
|
|
gptkbp:type_of_care
|
Important for efficacy
|